With scientists racing to develop a COVID-19 vaccine, leaders face the unprecedented challenge of manufacturing and distributing a vaccine worldwide. Euronews will speak to some of the world's leading experts to find out what hurdles we face and what solutions can be found.
COVAX aims to make 2 billion doses of COVID-19 vaccine available by the end of next year, although rich countries are said to have reserved more than half of the world’s global capacity.
Charities are calling for an overhaul of corporate practices so that a 'People's Vaccine' is available to everyone.
Police had tried to ban the march but the city court allowed it to go ahead with a limit of 1,000 participants — authorities estimated 3,000 turned up.
AstraZeneca, who is running the trials, is investigating whether the COVID-19 candidate vaccine recipient's "potentially unexplained” illness is a result of receiving the shot.
A peer review of trials of the Sputnik V vaccine published in The Lancet reports promising results, but adds that more work is needed.
Our bureau in Brussels takes a look at some of the key stories in Europe this week.
Consumer groups worry it could set a dangerous precedent.
The US government told states to prepare for a coronavirus vaccine to be ready to distribute by Nov. 1.
Russia has now had more than one million confirmed cases of coronavirus since the start of the outbreak, the fourth-highest total in the world.
Researchers found that respondents who are sceptical about science and authority are more likely to refuse the vaccine.
Coronavirus: EU says it struck deal with Sanofi for 300 million doses of potential COVID-19 vaccine